Back to News
Market Impact: 0.15
GenDx Co-Founder Wietse Mulder Invests $100,000 in AI Transplant Company Immunomatics and Joins as Strategic Advisor
Source: PRWeb
Artificial IntelligenceHealthcare & BiotechTechnology & InnovationPrivate Markets & Venture
Immunomatics, Inc. announced strategic backing and industry guidance from an experienced transplant diagnostics entrepreneur for its AI-based approach to transplant donor risk assessment. The provided article excerpt gives no financial terms, product results, or other details on the backing.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Why is SK Hynix stock gaining today?
- Asia shares subdued, bonds swamped by AI debt wave
- Elon Musk blames Indian 'oligarchs' for stalling Starlink launch
- Anthropic will be 'most ridiculous IPO' of year, analyst says
- Megacaps Are Back Driving the US Stock Rally in Hot-Running Economy
- Stock Rally Fades on Higher Oil Prices; SpaceX in Talks to Buy Nvidia Chips